Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response

被引：0
|
作者：
John C Lam
Ranjani Somayaji
Michael G Surette
Harvey R Rabin
Michael D Parkins
机构：
[1] The University of Calgary,Department of Medicine
[2] McMaster University,The Department of Microbiology, Immunology and Infectious Disease
[3] The University of Calgary,undefined
来源：
BMC Infectious Diseases | / 15卷
关键词：
Treatment; Biomarker; Failure; Outcome; Bronchiectasis; Cefepime; Heterogeneity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology
    Palmer, KL
    Mashburn, LM
    Singh, PK
    Whiteley, M
    JOURNAL OF BACTERIOLOGY, 2005, 187 (15) : 5267 - 5277
  • [42] Pseudomonas aeruginosa transcriptome analysis of metal restriction in ex vivo cystic fibrosis sputum
    Neff, Samuel L.
    Doing, Georgia
    Reiter, Taylor
    Hampton, Thomas H.
    Greene, Casey S.
    Hogan, Deborah A.
    MICROBIOLOGY SPECTRUM, 2024, 12 (04):
  • [43] Detection of antibodies against Pseudomonas aeruginosa in the sputum of cystic fibrosis patients: A pilot study
    Kelemen, Krisztina
    Csiszer, Eszter
    Barta, Imre
    Antus, Balazs
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [44] Direct sputum analysis of Pseudomonas aeruginosa macrorestriction fragment genotypes in patients with cystic fibrosis
    Stefanie Breitenstein
    Siegbert Walter
    Jutta Boßhammer
    U. Römling
    B. Tümmler
    Medical Microbiology and Immunology, 1997, 186 : 93 - 99
  • [45] Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa
    Pattison, Sally H.
    Gibson, David S.
    Johnston, Elinor
    Peacock, Samantha
    Rivera, Keith
    Tunney, Michael M.
    Pappin, Darryl J.
    Elborn, J. Stuart
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (01)
  • [46] Continuous glucose monitoring in a cystic fibrosis patient to predict pulmonary exacerbation?
    Inman, T. B.
    Lim, M.
    Proudfoot, J. A.
    Demeterco-Berggren, C.
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (05) : 628 - 630
  • [47] DO INFLAMMATORY BIOMARKERS PREDICT PULMONARY EXACERBATION IN PATIENTS WITH CYSTIC FIBROSIS?
    Emiralioglu, N.
    Aydemir, O.
    Kiper, N.
    Tugcu, G.
    Yalcin, E.
    Dogru, D.
    Ozcelik, U.
    PEDIATRIC PULMONOLOGY, 2016, 51 : S57 - S58
  • [48] Altered expression of long non-coding RNA in sputum and blood during pulmonary exacerbation in cystic fibrosis
    Stachowiak, Zuzanna
    Narozna, Beata
    Langwinski, Wojciech
    Wojsyk-Banaszak, Irena
    Potoczna, Katarzyna Jonczyk
    Breborowicz, Anna
    Szczepankiewicz, Aleksandra
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [49] Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules
    Schneider-Futschik, Elena K.
    Paulin, Olivia K. A.
    Hoyer, Daniel
    Roberts, Kade D.
    Ziogas, James
    Baker, Mark A.
    Karas, John
    Li, Jian
    Velkov, Tony
    ACS INFECTIOUS DISEASES, 2018, 4 (05): : 646 - 655
  • [50] Detection of anaerobic bacteria in sputum from Cystic Fibrosis patients with an acute pulmonary exacerbation
    Tunney, M.
    Moriarty, F.
    Field, T.
    Patrick, S.
    Doring, G.
    Elborn, S.
    PEDIATRIC PULMONOLOGY, 2007, : 311 - 312
12345